Particulars (Rupees in Crores.) | Jun-2025 | Mar-2025 | Dec-2024 | Sept-2024 | Jun-2024 |
---|---|---|---|---|---|
Gross Sales | 410.17 | 575.68 | 449.51 | 430.67 | 361.84 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 410.17 | 575.68 | 449.51 | 430.67 | 361.84 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 20.5 | -0.43 | -0.14 | 11.07 | 3.98 |
Total Income | 430.67 | 575.25 | 449.37 | 441.74 | 365.82 |
Total Expenditure | 309.96 | 398.05 | 336.94 | 324.09 | 276.83 |
PBIDT | 120.71 | 177.2 | 112.43 | 117.65 | 88.99 |
Interest | 12.18 | 11.33 | 10.72 | 9.02 | 11.02 |
PBDT | 108.53 | 165.87 | 101.71 | 108.63 | 77.97 |
Depreciation | 12.25 | 10.24 | 8.58 | 9.22 | 8.41 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 22.03 | 44.62 | 19.96 | 22.88 | 16.06 |
Deferred Tax | 2.83 | 2.04 | -7.07 | 0.66 | 2.58 |
Reported Profit After Tax | 71.42 | 108.97 | 80.24 | 75.88 | 50.92 |
Minority Interest After NP | 0 | 0 | 0 | 0 | 0 |
Net Profit after Minority Interest | 71.42 | 108.97 | 80.24 | 75.88 | 50.92 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 71.42 | 108.97 | 80.24 | 75.88 | 50.92 |
EPS (Unit Curr.) | 3.14 | 4.79 | 3.53 | 3.33 | 2.24 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 45.48 | 45.48 | 45.48 | 45.49 | 45.49 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 29.42 | 30.78 | 25.01 | 27.31 | 24.59 |
PBDTM(%) | 26.45 | 28.81 | 22.62 | 25.22 | 21.54 |
PATM(%) | 17.41 | 18.92 | 17.85 | 17.61 | 14.07 |
Roughly 1.37 crore shares changed hands in the block window, representing about 6.06% of the company’s total outstanding equity.
At the end of the June quarter, Paresh owned 1.12% of Sun Pharma Advanced Research, while his brother Vijay owned 1.13% of the company.
Here are some of the stocks that may see significant price movement today: HPCL, PNB Housing, Colgate-Palmolive, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.